Olivier Danos, PhD, on Enhancing Gene Therapy for DMD
The chief scientific officer at REGENXBIO discussed RGX-202 and the ongoing clinical trial.
Olivier Danos, PhD, on Refining and Specifying AAV Gene Therapy
The chief scientific officer at REGENXBIO discussed multiple presentations given by the company at the 2023 ASGCT meeting.